RAD Technology Medical Systems Partners with Belimed to Provide Portable SPD Solutions

RAD Technology Medical Systems (RAD Technology) and Belimed Inc. (Belimed) are pleased to announce a partnership in portable sterilization services. RAD Technology, a provider of design-built modular facilities, will combine their healthcare construction expertise with Belimed’s medical and surgical instrument sterilization, disinfection and cleaning product services. Together, the two companies will provide fully equipped portable Sterile Processing Department (SPD) solutions to a burgeoning US surgical market.

The mobile facility, known as FlexSPD, is designed to meet the sterilization demands of new and growing hospitals and surgery centers. The FlexSPD can be located on an existing campus or at an offsite location. It can be used to decrease the demand on an existing SPD, serve as the primary sterilization solution for new practices or satellite facilities, or provide interim services during renovations or large construction projects.

The 24’x37′ temporary unit arrives fully built out with large capacity Washer-Disinfectors and Sterilizers, a Triple Basin Processing Sink, an Ultrasonic Washer, and Prep and Pack Workstations to fully meet the daily needs of an SPD in an efficient modular package. The building’s small footprint allows it to be easily and quickly installed on nearly any site. In addition, the facility is portable, allowing healthcare providers to relocate it to a variety of locations as needed.

“We are pleased to be able to combine our modular technology and healthcare construction knowledge with Belimed’s equipment and sterile workflow solutions,” said Kenneth Wright, RAD Technology’s Vice President of Sales and Business Development. “We believe the FlexSPD will be the perfect back of house solution for hospitals and surgery centers trying to meet the growing demand for their services.”

The FlexSPD is expected to be available for lease starting Q4 of 2023.

“We are thrilled to be partnering with RAD Technology to provide this unique solution to our customers,” said Sean O’Brien, Vice President, Enterprise Solutions and Business Development at Belimed. “RAD Technology’s strength of space optimization, best in class design and forward-thinking technology aligns so well with our own at Belimed. We cannot wait to get these units into the market to meet the growing sterile processing needs of so many.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”